Page last updated: 2024-10-21

hydroxyindoleacetic acid and MPTP Neurotoxicity Syndrome

hydroxyindoleacetic acid has been researched along with MPTP Neurotoxicity Syndrome in 13 studies

(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.

Research Excerpts

ExcerptRelevanceReference
"Trichostatin A (TSA) was further used to study the effects of histone deacetylase inhibition on NRSF-mediated repression."1.42NRSF is an essential mediator for the neuroprotection of trichostatin A in the MPTP mouse model of Parkinson's disease. ( Cai, L; Fei, J; Huang, D; Huang, F; Huang, L; Huang, Y; Liu, J; Ma, Y; Suo, H; Tong, J; Wang, P; Wang, Z; Xu, J; Yu, M, 2015)

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (53.85)18.2507
2000's1 (7.69)29.6817
2010's5 (38.46)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jones, BC1
Miller, DB1
O'Callaghan, JP1
Lu, L1
Unger, EL1
Alam, G1
Williams, RW1
Saitoh, K1
Abe, K1
Chiba, T1
Katagiri, N1
Saitoh, T1
Horiguchi, Y1
Nojima, H1
Taguchi, K1
Suo, H1
Wang, P1
Tong, J1
Cai, L1
Liu, J1
Huang, D1
Huang, L1
Wang, Z1
Huang, Y1
Xu, J1
Ma, Y2
Yu, M1
Fei, J1
Huang, F1
Maiti, P1
Gregg, LC1
McDonald, MP1
Li, XM1
Ma, HB1
Ma, ZQ1
Li, LF1
Xu, CL1
Qu, R1
Ma, SP1
Li, H1
He, Z1
Su, T1
Lu, S1
Dai, C1
Sun, M1
Pérez-Otaño, I1
Luquin, MR1
Oset, C1
Herrero, MT1
Kupsch, A1
Oertel, W1
Obeso, JA1
Del Río, J1
Tanila, H1
Björklund, M1
Riekkinen, P1
Cheng, FC1
Ni, DR1
Wu, MC1
Kuo, JS1
Chia, LG1
Donovan, DM1
Miner, LL1
Perry, MP1
Revay, RS1
Sharpe, LG1
Przedborski, S1
Kostic, V1
Philpot, RM1
Kirstein, CL1
Rothman, RB1
Schindler, CW1
Uhl, GR1
Bankiewicz, KS1
Plunkett, RJ1
Mefford, I1
Kopin, IJ1
Oldfield, EH1
Russ, H1
Mihatsch, W1
Gerlach, M1
Riederer, P1
Przuntek, H1
Bonuccelli, U1
Garant, D1
Fariello, R1

Other Studies

13 other studies available for hydroxyindoleacetic acid and MPTP Neurotoxicity Syndrome

ArticleYear
Systems analysis of genetic variation in MPTP neurotoxicity in mice.
    Neurotoxicology, 2013, Volume: 37

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biomarkers; Brain; Disease Models, Animal; Dopamine; Gene E

2013
Properties of 3-methyl-TIQ and 3-methyl-N-propargyl-TIQ for preventing MPTP-induced parkinsonism-like symptoms in mice.
    Pharmacological reports : PR, 2013, Volume: 65, Issue:5

    Topics: Animals; Antiparkinson Agents; Basal Ganglia; Behavior, Animal; Disease Models, Animal; Dopamine; Do

2013
NRSF is an essential mediator for the neuroprotection of trichostatin A in the MPTP mouse model of Parkinson's disease.
    Neuropharmacology, 2015, Volume: 99

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Cell Line, Tumor; Dopamine; Drug Evaluation, Preclin

2015
MPTP-induced executive dysfunction is associated with altered prefrontal serotonergic function.
    Behavioural brain research, 2016, Feb-01, Volume: 298, Issue:Pt B

    Topics: Animals; Attention; Corpus Striatum; Disease Models, Animal; Dopamine; Executive Function; Hydroxyin

2016
Ameliorative and neuroprotective effect in MPTP model of Parkinson's disease by Zhen-Wu-Tang (ZWT), a traditional Chinese medicine.
    Journal of ethnopharmacology, 2010, Jul-06, Volume: 130, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Chromatography, High Pressure Liquid; Cor

2010
Protective action of recombinant neurturin on dopaminergic neurons in substantia nigra in a rhesus monkey model of Parkinson's disease.
    Neurological research, 2003, Volume: 25, Issue:3

    Topics: Animals; Behavior, Animal; Cell Count; Dopamine; Hydroxyindoleacetic Acid; Injections, Intraventricu

2003
Neurotoxicity induced by prenatal exposure to MPTP on the monoaminergic and peptidergic systems of the marmoset brain.
    Experimental neurology, 1995, Volume: 131, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Callithrix; Dopamine; Enkephalin, Methionine; Female

1995
Cognitive changes in mice following moderate MPTP exposure.
    Brain research bulletin, 1998, Volume: 45, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic alpha-Agonists; Animals; Cerebral Cortex; Cognition; Corp

1998
Glial cell line-derived neurotrophic factor protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in C57BL/6 mice.
    Neuroscience letters, 1998, Aug-14, Volume: 252, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Brain Chemistry; Disease Models, Animal;

1998
Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression.
    Brain research. Molecular brain research, 1999, Nov-10, Volume: 73, Issue:1-2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Ani

1999
Behavioral recovery from MPTP-induced parkinsonism in monkeys after intracerebral tissue implants is not related to CSF concentrations of dopamine metabolites.
    Progress in brain research, 1990, Volume: 82

    Topics: Adrenal Medulla; Amnion; Animals; Brain Tissue Transplantation; Caudate Nucleus; Disease Models, Ani

1990
Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: implications for Parkinson's disease?
    Neuroscience letters, 1991, Feb-11, Volume: 123, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amin

1991
The acute convulsant effect of MPTP is dependent on intracerebral MPP+.
    Neuroscience letters, 1991, Mar-11, Volume: 124, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemist

1991